Royalty Pharma plc (RPRX)
NASDAQ: RPRX · IEX Real-Time Price · USD
28.76
+0.69 (2.46%)
At close: May 2, 2024, 4:00 PM
28.79
+0.03 (0.10%)
Pre-market: May 3, 2024, 5:22 AM EDT
Royalty Pharma Revenue
In the year 2023, Royalty Pharma had annual revenue of $2.35B with 5.24% growth. Revenue in the quarter ending December 31, 2023 was $596.07M with 5.36% year-over-year growth.
Revenue (ttm)
$2.35B
Revenue Growth
+5.24%
P/S Ratio
5.51
Revenue / Employee
$26,455,663
Employees
89
Market Cap
12.97B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.35B | 117.34M | 5.24% |
| Dec 31, 2022 | 2.24B | -52.25M | -2.28% |
| Dec 31, 2021 | 2.29B | 167.11M | 7.87% |
| Dec 31, 2020 | 2.12B | 308.10M | 16.98% |
| Dec 31, 2019 | 1.81B | 19.36M | 1.08% |
| Dec 31, 2018 | 1.79B | 196.96M | 12.33% |
| Dec 31, 2017 | 1.60B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Walgreens Boots Alliance | 144.60B |
| Fresenius Medical Care AG & Co. KGaA | 21.62B |
| Viatris | 15.43B |
| Quest Diagnostics | 9.29B |
| Dr. Reddy's Laboratories | 2.99B |
| Revvity | 2.75B |
| Medpace Holdings | 1.96B |
| Neurocrine Biosciences | 1.89B |
RPRX News
- 15 hours ago - Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma - Business Wire
- 13 days ago - Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewsWire
- 15 days ago - Royalty Pharma Declares Second Quarter 2024 Dividend - GlobeNewsWire
- 2 months ago - Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Royalty Pharma Reports Q4 and Full Year 2023 Results - GlobeNewsWire
- 3 months ago - Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024 - GlobeNewsWire
- 3 months ago - Royalty Pharma Announces Dividend Increase - GlobeNewsWire
- 5 months ago - Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference - GlobeNewsWire